ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2015, Vol. 24 ›› Issue (4): 307-312.

• 论文 • 上一篇    下一篇

肾病综合征患者合并无菌性股骨头坏死

  

  • 出版日期:2015-08-28 发布日期:2015-09-01

Avascular bone necrosis in patients with primary nephrotic syndrome

  • Online:2015-08-28 Published:2015-09-01

摘要:

 【摘要】 目的 分析原发性肾小球疾病(FSGS、IgM肾病、微小病变肾病)肾病综合征患者合并无菌性股骨头坏死的临床特点及危险因素。方法 回顾性分析2009年1月至2013年12月随访期间原发性肾小球疾病肾病综合征激素治疗后合并股骨头坏死的临床资料。结果:3796例原发性肾小球疾病肾病综合征门诊随访患者中并发股骨头坏死人数为92人(2.4%)。股骨头坏死组在激素治疗3年内发生股骨头坏死比例为80.4%。多因素Logistic回归分析结果显示低白蛋白血症是原发性肾小球疾病肾病综合征患者并发股骨头坏死的危险因素(P<0.05)。股骨头坏死组对激素治疗反应、肾病复发次数及糖皮质激素累积用量与非股骨头坏死组两者统计学无差异(P>0.05)。股骨头坏死组血浆白蛋白降低、纤维蛋白原升高及血钙水平降低的患者与非股骨头坏死组有统计学差异(P<0.05)。预防使用维生素D制剂及钙剂不能降低股骨头坏死发生率。股骨头坏死组与非股骨头坏死组之间年龄、性别、24小时尿蛋白定量、血色素、血小板、尿酸、甘油三酯、总胆固醇、低密度脂蛋白胆固醇、低密度脂蛋白胆固醇与高密度脂蛋白胆固醇比值、血磷无统计学差异(P>0.05)。结论:原发性肾小球疾病肾病综合征患者合并股骨头坏死的发生率为2.4%,在激素治疗3年内并发股骨头坏死的发生率最高。低蛋白血症是原发性肾小球疾病肾病综合征合并股骨头坏死的危险因素。股骨头坏死组与非股骨头坏死组之间对激素治疗反应、肾病复发次数及糖皮质激素累积用量两者无统计学差异。起病时血浆白蛋白低、纤维蛋白原高、低血钙水平与股骨头坏死发生相关。预防使用维生素D制剂及钙剂不能降低股骨头坏死发生率。对高危患者在激素治疗5月内定期行影像学检查以早期发现股骨头坏死。

关键词: 原发性肾小球疾病, 肾病综合征, 股骨头坏死, 糖皮质激素

Abstract:

【Abstract】Objective:To investigate the clinical features of osteonecrosis of the femoral head (ONFH) in patients with idiopathic primary glomerulopathy nephrotic syndrome. Methods:A retrospective analysis of outpatients from January 2009 to December 2013 with ONFH the clinical data of follow-up. Results:The incidence of ONFH in 3796 idiopathic primary glomerulopathy nephrotic syndrome patients which include FSGS, IgM nephropathy and minimal change nephropathy was 2.4%. 80.4% of the ONFH group was diagnosed within the first 3 years of corticosteroid therapy. Multiple factor logistic regression analysis revealed that hypoproteinemia was the risk factor of ONFH (P<0.05).There was no significant difference between two groups in glucocorticoid therapy response,the recurrence frequency of nephropathy and accumulative dosage of glucocorticoid (P>0.05).Preventive use of vitamin D and calcium can not reduce the occurrence of ONFH. There was no difference in sex, age, 24-hour urine albumin excretion, hemoglobin, blood platelet,uric acid,triglyceride,total cholesterol, LDL-C ,the ratio LDL-C to HDL-C, blood phosphorus between the two groups(P>0.05).Conclusions: The incidence of ONFH in patient with primary glomerulopathy nephrotic syndrome was 2.4%.The ONFH has the highest occurrence within 3 years of Glucocorticoid therapy. Hypoproteinemia is the risk factor with ONFH. There was no significant difference between two groups in glucocorticoid therapy response,the recurrence frequency of nephropathy and accumulative dosage of glucocorticoid . The incidence of ONFH in patients with primary glomerulopathy nephrotic syndrome are more likely to have such clinical features as low serum albumin and blood cacium, high serum fibrinogen .Preventive use of vitamin D and calcium can not reduce the occurrence of ONFH.They should do MRI test of the hip joint routinely when the time of glucocorticoid treatment for 5 months.

Key words: primary glomerulopathy, nephritic syndrome, osteonecrosis of the femoral head, glucocorticoid